You are looking for

Many public health campaigns focus on the importance of identifying and acting on the symptoms of major cardiovascular disease (CVD) events, such as heart attacks and strokes, as quickly as possible. Medicine has developed so much in recent decades that these events, which were once a death sentence for the majority, are now often survivable […]

At the MedTech Forum that took place in Barcelona earlier this year, I joined a J&J MedTech sponsored panel entitled Data Governance in a Patient Pathway. I was on stage with peers from the industry, all looking at the topic from a different perspective, from the patient, to the healthcare provider, the policy maker to […]

As lawyers we tend to use academic journals to tease out complex legal questions. (See our latest contribution to the literature here). However, today we’re taking the opportunity to discuss a hot topic with a broader audience, as we feel it will have a profound impact on the public, patients and health systems. That topic […]

The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.

COVID-19 has changed healthcare industry forever. The unparalleled demands placed on healthcare systems have disrupted old ways and exposed cracks but also opened our eyes to new possibilities. I was so inspired to see people pulling together, refusing to give up, and our industry showing a resilience to bring innovations to the market that positively […]

When our partners launched the European Alliance for Cardiovascular Health in September 2021, we were driven by the commitment to share expertise and raise awareness on the burden of cardiovascular diseases (CVDs) in Europe. We knew then, and our Alliances of 17 partners knows today, that cardiovascular diseases understood as a vast group of disorders, […]

We need to start a conversation now about how to prepare our systems and societies for the changes on the horizon. In the second of a two-part mini-series on predictive genomics, Francesco Floridini examines how Europe can accelerate the transition. I believe technology is no longer the key barrier to unlocking the potential of predictive […]

Predictive genomics can transform healthcare, shifting the focus towards prevention and getting better value for the money we spend. In the first of a two-part mini-series, Francesco Floridini explores this new paradigm in healthcare. Healthcare today is all about treating people who are ill. They experience symptoms, engage with the health system, and receive an […]

It’s hard to think of information that feels more personal than data about our own health. Yet we’re generating and monitoring more health data now than ever before. From specific technology designed to help manage certain medical conditions to home monitoring tools, there are more and more digital options to help manage patient health. The […]